Bayesian design for clinical trials with a constraint on the total available dose (Q2736795)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian design for clinical trials with a constraint on the total available dose |
scientific article; zbMATH DE number 1644899
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Bayesian design for clinical trials with a constraint on the total available dose |
scientific article; zbMATH DE number 1644899 |
Statements
11 September 2001
0 references
Bayesian optimal design
0 references
dose response trial
0 references
0.92030966
0 references
0.9192105
0 references
0.9181172
0 references
0.90311843
0 references
0.90297383
0 references
0.9025865
0 references
Bayesian design for clinical trials with a constraint on the total available dose (English)
0 references
